JP2024527175A5 - - Google Patents
Info
- Publication number
- JP2024527175A5 JP2024527175A5 JP2023543464A JP2023543464A JP2024527175A5 JP 2024527175 A5 JP2024527175 A5 JP 2024527175A5 JP 2023543464 A JP2023543464 A JP 2023543464A JP 2023543464 A JP2023543464 A JP 2023543464A JP 2024527175 A5 JP2024527175 A5 JP 2024527175A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PT2021/050001 WO2022158991A1 (en) | 2021-01-20 | 2021-01-20 | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa |
| PTPCT/PT2021/050001 | 2021-01-20 | ||
| PCT/PT2021/050026 WO2022158992A1 (en) | 2021-01-20 | 2021-08-04 | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024527175A JP2024527175A (ja) | 2024-07-22 |
| JPWO2022158992A5 JPWO2022158992A5 (https=) | 2024-07-29 |
| JP2024527175A5 true JP2024527175A5 (https=) | 2024-07-29 |
Family
ID=74494985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543464A Pending JP2024527175A (ja) | 2021-01-20 | 2021-08-04 | レボドパと組み合わせるオピカポンを用いたパーキンソン病に関連する疼痛の治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240066015A1 (https=) |
| EP (1) | EP4281071A1 (https=) |
| JP (1) | JP2024527175A (https=) |
| CN (1) | CN116963735A (https=) |
| WO (2) | WO2022158991A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3860603A1 (en) | 2018-10-05 | 2021-08-11 | Neurocrine Biosciences, Inc. | Methods for the administration of comt inhibitors |
| EP4360627A1 (fr) * | 2022-10-26 | 2024-05-01 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Traitement de l'arthrose par des inhibiteurs de comt |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20000635A0 (fi) * | 2000-03-17 | 2000-03-17 | Orion Yhtymae Oyj | COMT-inhibiittoreiden käyttö analgeettina |
| JP5435165B2 (ja) * | 2012-05-31 | 2014-03-05 | 小野薬品工業株式会社 | 医薬用途 |
| PT3782617T (pt) * | 2014-09-04 | 2024-02-29 | Lobsor Pharmaceuticals Ab | Composições farmacêuticas de gel compreendendo levodopa, carbidopa e entacapona |
| JP2018500300A (ja) * | 2014-11-28 | 2018-01-11 | ノヴィファーマ，エス．アー． | パーキンソン病を遅延させるための医薬 |
| MX383906B (es) * | 2015-10-09 | 2025-03-14 | Teva Pharmaceuticals Int Gmbh | Combinación de levodopa deuterado con carbidopa y opicapona para el tratamiento del mal de parkinson |
| JP2024500754A (ja) * | 2020-12-17 | 2024-01-10 | ビアル－ポルテラ エ コンパニア，ソシエダッド アノニマ | 早期特発性パーキンソン病のための治療レジメン |
-
2021
- 2021-01-20 WO PCT/PT2021/050001 patent/WO2022158991A1/en not_active Ceased
- 2021-08-04 JP JP2023543464A patent/JP2024527175A/ja active Pending
- 2021-08-04 WO PCT/PT2021/050026 patent/WO2022158992A1/en not_active Ceased
- 2021-08-04 CN CN202180095156.0A patent/CN116963735A/zh active Pending
- 2021-08-04 US US18/273,515 patent/US20240066015A1/en active Pending
- 2021-08-04 EP EP21752278.8A patent/EP4281071A1/en active Pending